Cathepsin B (CTSB) and cathepsin L (CTSL) are two widely expressed cysteine proteases thought to predominantly reside within lysosomes. Functional analysis of CTSL in humans is complicated by the existence of two CTSL-like homologs (CTSL and CTSL2), in contrast to mice, which possess only one CTSL enzyme. Thus, transgenic expression of human CTSL in CTSL-deficient mice provides an opportunity to study the in vivo functions of this human protease without interference by its highly related homolog. While mice with single-gene deficiencies for murine CTSB or CTSL survive without apparent neuromuscular impairment, murine CTSB/CTSL double-deficient mice display degeneration of cerebellar Purkinje cells and neurons of the cerebral cortex, resulting in severe hypotrophy, motility defects, and lethality during their third to fourth week of life. Here we show that expression of human CTSL through a genomic transgene results in widespread expression of human CTSL in the mouse that is capable of rescuing the lethality found in CTSB/CTSL double-deficient animals. Human CTSL is expressed in the brain of these compound mutants, predominantly in neurons of the cerebral cortex and in Purkinje cells of the cerebellum, where it appears to prevent neuronal cell death.
Introduction
Cathepsins are proteolytic enzymes with a principal subcellular localization in the endosomal/lysosomal compartment. The largest family of cathepsins comprises the papain-like cysteine proteases, with 11 human enzymes (Turk et al., 2001) . As a result of a gene duplication, the human genome encodes for two cathepsin L-like proteases, namely the 'classic' human cathepsin L (CTSL), which is produced by a wide range of tissue and cell types, as well as cathepsin L2 (CTSL2; alternatively termed cathepsin V), with a more restricted expression pattern (Brö mme and Kaleta, 2002) . In contrast, the mouse genome contains only one CTSL gene, which is ubiquitously expressed (Brö mme and Kaleta, 2002). All three enzymes, murine CTSL, human CTSL and human CTSL2, are highly homologous with approximately 75% amino acid identity, which complicates the assignment of biological functions to the human enzymes (Brö mme and Kaleta, 2002; Hagemann et al., 2004) . Thus, we sought to study the expression of human CTSL in CTSLdeficient mice to assess in vivo functions of the human protease without interference by its highly related homolog.
CTSL-deficient mice develop dilated cardiomyopathy (Stypmann et al., 2002) , as well as epidermal hyperproliferation, retardation of hair follicle morphogenesis and alterations of the hair cycle Reinheckel et al., 2005; Tobin et al., 2002) . Murine CTSL is critical for major histocompatibility complex (MHC) class IImediated antigen presentation in cortical epithelial cells of the thymus (Nakagawa et al., 1998; Honey et al., 2002) . Furthermore, CTSL is involved in generating hypophyseal neuropeptides (i.e., enkephalin) and, in combination with cathepsins K and B, is responsible for solubilization of thyroglobulin and the release of thyroid hormones (Friedrichs et al., 2003; Yasothornsrikul et al., 2003) . Recently, the critical role of CTSL for endothelial progenitor cell-induced neovascularization in a hind-limb ischemia model was demonstrated (Urbich et al., 2005) . However, CTSL knockout mice are fertile, reproduce normally and do not develop a pathological neuromuscular phenotype. In contrast to CTSL-deficient animals, CTSB knockout mice do not show any obvious spontaneous phenotype (Reinheckel et al., 2001 ). Nevertheless, under environmental stress experiments, CTSB was shown to have a major role in pathological trypsinogen activation in the early course of experimental pancreatitis (Halangk et al., 2000) , as well as to contribute significantly to TNFa-induced hepatocyte apoptosis (Guicciardi et al., 2000) . In contrast to the single gene mutations, CTSB/CTSL double-mutant mice exhibit a severely impaired life expectancy. While mice with CTSB/CTSL double deficiency are born at the expected Mendelian ratios, they die during their third to fourth week of life (Felbor et al., 2002) . The authors proposed that this lethality is most likely due to degeneration of cerebellar Purkinje cells and neurons of the cerebral cortex, which results in severe hypotrophy, motility defects, and ultimately death (Felbor et al., 2002) .
The aim of the present study was to express human CTSL from a genomic transgene and to compare postnatal development, brain histology and cathepsin L expression of the triple mutant Tg(hCTSL); 
Results

Expression of transgenic human CTSL
We previously generated a human CTSL transgenic mouse using a publicly available Bacterial Artificial Chro- mosome clone (CTD-2062O4) (Houseweart et al., 2003) .
To assess the expression of the transgene, we examined human CTSL mRNA and protein levels, as well as enzyme activity, in a panel of mouse tissues (Figure 1 ). Amplification of a specific 152-bp fragment of human CTSL cDNA was observed after RT-PCR of RNAs isolated from the human cell line HEK293 or from liver of transgenic Tg(hCTSL) mice, while material from nontransgenic mice did not show a specific RT-PCR product ( Figure 1A ). Using these primers in quantitative real-time RT-PCR, we determined the relative level of the hCTSL transcript in several tissues from these transgenic mice ( Figure 1B ). Liver, followed by kidney, showed the highest level of human CTSL mRNA expression, while heart, skeletal muscle and brain displayed lower expression. This expression pattern was largely confirmed by Western blotting, although kidney revealed somewhat higher abundance of human CTSL than liver, suggesting a difference in their post-transcriptional processing ( Figure  1C ). In contrast to the other tissues, pro-CTSL was almost undetectable in brain samples, indicating that the protease is predominantly activated in the central nervous system. Furthermore, we compared degradation of the common CTSL substrate z-Phe-Arg-AMC (in the presence of the specific CTSB inhibitor CA074) in samples from wild-type and triple mutant Tg(hCTSL);Ctsb
Ctsl -/-mice, which are deficient for the murine proteases CTSB and CTSL ( Figure 1D ). Comparison of wild-type and transgenic mice revealed that degradation of the fluorogenic peptide was widely different, with livers and kidneys of transgenic mice showing four-and 10-fold higher z-Phe-Arg-AMC cleavage compared to wild-type mice. In contrast, CTSL activities in cerebral cortex and cerebellum were similar to those in control animals (Figure 1D) . In summary, these data indicate that the genomic transgene exerts control on tissue-specific expression quantities of human CTSL in the mouse, and a proteolytically active human CTSL is produced. However, these transgenic mice appear outwardly normal, with no apparent effects on fertility, reproduction or viability. To determine if the human transgene could complement the mouse CTSB/CTSL-deficient phenotypes, we crossed them consecutively with CTSB and CTSL knockout mice to obtain the triple mutant Tg(hCTSL);Ctsb
The lethal phenotype of CTSB/CTSL doubledeficient mice is rescued by the expression of human CTSL
In contrast to the study of Felbor et al. (2002) , which used CTSB/CTSL double-deficient mice of a mixed C57BL/ 6.129P2 genetic background, the CTSB/CTSL doubledeficient mice used in the present study were backcrossed for at least six generations to the FVB/n background, resulting in a more uniform genetic background since their original generation (Halangk et al., 2000; Roth et al., 2000) . (Figure 2A ), while body weight was similar to the Ctsb -/-Ctsl q/-control mice that showed a weight gain identical to FVB/n wild-type mice ( Figure 2B ). However, CTSB/CTSL double-deficient mice developed severe hypotrophy and neuromuscular dysfunction, characterized by ataxia, mild rear-limb spasticity, and physical inactivity, during the next 7-10 days of life. This phenotype was completely rescued by expression of human CTSL in Tg(hCTSL);Ctsb -/-Ctsl -/-mice (Figure 2A,B) . The body weight of Ctsb -/-Ctsl -/-males and females ranged between 3 and 5 g in the fourth week of life, and animals were sacrificed at this stage. In contrast, males and females of the triple mutant Tg(hCTSL);Ctsb
showed a slightly retarded weight gain during the third to fifth weeks of life; however, at 35 days, body weights reached the control group and mice were viable for observation periods of up to 1 year ( Figure 2B , and data not shown). Interestingly, Tg(hCTSL);Ctsb -/-Ctsl -/-mice showed the periodic hair loss that is characteristic for mice with single deficiency for the murine CTSL ( Figure  2A ). or CTSL showed a normal Purkinje cell layer (Figure 3 A-E). The other layers of the cerebellar cortex, namely the molecular and granular cell layers, did not exhibit histomorphological alterations. Strikingly, the triple mutant Tg(hCTSL);Ctsb -/-Ctsl -/-showed a complete rescue of Purkinje cells ( Figure 3E ).
To localize CTSL expression in mouse cerebral and cerebellar cortex, immunohistochemistry for murine CTSL and for transgenic human CTSL was performed (Figures 4 and 5) . In the cerebral cortex, murine CTSL is highly expressed in the pyramidal cell neurons ( Figure  4A,B) . This cerebral expression pattern is clearly recapitulated by the expression of human CTSL in Tg(hCTSL); Ctsb -/-Ctsl -/-mice ( Figure 5A,B) . However, histopathological lesions were not detected in the cerebral cortex of CTSB/CTSL double-deficient FVB/n congenic mice (Figure 5C,D) . Murine CTSL is highly abundant in cerebellar Purkinje cells, with a staining intensity clearly exceeding the decoration of the other cell layers ( Figure 4D ). Strikingly, human CTSL is strongly expressed by the cerebellar Purkinje cell layer of Tg(hCTSL);Ctsb -/-Ctsl -/-mice ( Figure 5E,F) . Thus, both the mouse CTSL and transgenic human CTSL are expressed in similar patterns in the brain. Furthermore, transgene expression in Purkinje cells is associated with the prevention of Purkinje cell death, supporting the intrinsic need for the activity of cysteine cathepsins in these specific cells of the cerebellum.
Discussion
Because of their principal endosomal/lysosomal localizations and redundant substrate specificities, cysteine cathepsins are thought to cooperate in lysosomal proteolytic processes (Ciechanover, 2005) . The brain phenotype of CTSB/CTSL double-deficient mice provides a clear example of the functional redundancy among lysosomal cathepsins, since mice with single deficiencies of CTSB or CTSL do not show neuronal loss or neuromuscular symptoms. Cerebellar Purkinje cells, which are critical for the refinement of movements, are highly susceptible to the combined loss of cathepsins B and L. Although present after birth (Felbor et al., 2002) , these cells degenerate during the first weeks of life. In contrast to Felbor et al. (2002) , cerebral atrophy and astrogliosis were not observed in our analysis of Ctsb -/-Ctsl -/-mice. This might be explained by the fact that Felbor et al. (2002) nursed some Ctsb -/-Ctsl -/-mice up to the age of 50 days, at which point marked cerebral atrophy was found. Thus, it appears that degeneration of Purkinje cells represents an early pathogenic event in the brain of CTSB/CTSL double-deficient mice while cerebral atrophy occurs later in the pathogenesis.
Extending the study of Felbor et al. (2002) , we report an expression pattern of murine CTSL in wild-type brain that corresponds to the cell types that are highly susceptible to the loss of cathepsins, namely cerebellar Purkinje cells and neurons of the cerebral pyramidal cell layer. Remarkably, the human CTSL genomic transgene shows a similar expression pattern and CTSL activity as endogenous mouse CTSL in the brain. Most importantly, expression of the human CTSL transgene in CTSB/CTSL double-deficient mice prevented Purkinje cell loss and lethality, a result that provides further evidence for the functional redundancy among cathepsins. Since mouse cathepsin B exhibits identical brain localizations as CTSL (unpublished data), it remains to be determined whether transgenic expression of human CTSB would rescue the neuronal phenotype of Ctsb -/-Ctsl -/-mice to the same extent as human CTSL.
Interestingly, not all phenotypes of Ctsb -/-Ctsl -/-mice are rescued by the human CTSL transgene. The early postnatal phenotype of mice with CTSB/CTSL double deficiency is characterized by a delay in hair development, which is also a hallmark of mice with single deficiency of CTSL Tobin et al., 2002) . As shown in Figure 2 , Tg(hCTSL);Ctsb -/-Ctsl -/-mice still show this characteristic pattern of hair loss, while human CTSV (Hagemann et al., 2004) and mouse CTSL (Reinheckel et al., 2005) expressed in keratinocytes of hair follicles and of the basal epidermal layer under control of a cytokeratin 14 promotor rescue the skin phenotype of CTSL knockout mice. The question as to whether active human CTSL is expressed in keratinocytes of Tg(hCTSL) mice or if human CTSL is not capable of executing the murine CTSL functions in these cell types is currently under investigation.
Over the past years, evidence of cell type-specific functions of lysosomal cysteine cathepsins in the brain has been accumulating. As discussed above, cerebellar Purkinje cells are affected by the combined loss of cathepsins B and L. Interestingly, mutations of the cysteine protease inhibitor cystatin B (stefin B) result in apoptosis of cerebellar granule cells and cause progressive ataxia and a progressive myoclonus epilepsy (EPM1; Unverricht-Lundborg disease) in humans and in a mouse model (Pennacchio et al., 1996 (Pennacchio et al., , 1998 Lieuallen et al., 2001) . Breeding of cathepsin B-deficient mice to cystatin B knockout mice could ameliorate the neurological phenotype (Houseweart et al., 2003) . Thus, an excess of cysteine cathepsin activity, i.e., CTSB activity, in the cerebellum contributes to the neurodegeneration of granule cells, while the loss of cysteine cathepsins results in degeneration of the neighboring Purkinje cells. Deletion of another cysteine cathepsin inhibitor, cystatin C, promotes neuronal injury after focal brain ischemia, but is protective after global ischemia, indicating a fine balance of cysteine cathepsins and their inhibitors in pathological processes of the brain (Olsson et al., 2004) . Furthermore, CTSB has been implicated in the generation of b-amyloid in the regulated secretory pathway of neuronal chromaffin cells and, therefore, in Alzheimer's neurodegenerative disease (Hook et al., 2005) . CTSL has been shown to be involved in the processing of hypophyseal neuropeptides, i.e., enkephalin, from their precursor molecule (Yasothornsrikul et al., 2003; Hook et al., 2004) .
In summary, present evidence indicates cell type-specific functions of cysteine cathepsins in various physiological and pathological processes of the central nervous system. This study of a transgene expressed human cathepsins in the absence of their murine orthologs provides a valuable tool for investigation of the in vivo functions of the human enzymes in the brain. Our present results correlate the expression of human CTSL to the prevention of Purkinje cell degeneration and to the rescue of the severe neuromuscular phenotype of mice with double deficiency for CTSB and CTSL.
Materials and methods
Animals
Generation of Tg(hCTSL) mice has been described by Houseweart et al. (2003) . Briefly, a human CTSL BAC clone (CTD-2062O4) was identified by a sequence homology search, and BAC DNA was micro-injected into pro-nuclei of fertilized FVB oocytes using standard procedures. Cathepsin B-and cathepsin L-deficient mice (Halangk et al., 2000 were backcrossed for at least six generations on an FVB/n background. 
RT-PCR and quantitative real-time PCR
Total RNA from the human cell line HEK293 and murine tissues was prepared using an RNeasy Mini kit (Qiagen, Hilden, Germany). Reverse transcription for the generation of cDNA from total RNA was performed using a first-strand cDNA synthesis kit (Invitrogen, Karlsruhe, Germany). For expression analysis of human cathepsin L and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), PCR amplification was performed using equivalent amounts of the intercalating SYBR-green dye, cDNA/RNA, Taq polymerase, and specific primers (hCTSL, 59-GAA TCC TAC ACT CAT CCT TGC TGC C-39 and 59-ACA CTG CTC TCC TCC ACT CTT CTT C-39; GAPDH, 59-TGC ACC ACC AAC TGC TTA-39 and 59-GAT GCA GGG ATG ATG TTC-39) under the following conditions: 1 cycle for 1 min at 728C, 50 cycles (948C for 15 s, 608C for 30 s, 728C for 30 s) and 1 cycle at 728C for 7 min in a MyiQீ single-color real-time PCR detection system (Bio-Rad, Mü nchen, Germany). The resulting PCR products were visualized by ethidium bromide staining after separation on 1.5% (w/ v) agarose gels.
Detection of human cathepsin L by Western blotting
Murine tissues (100 mg) were homogenized in 500 ml of homogenization buffer (10 mM Tris, 128 mM NaCl, 1 mM EDTA, 1 mM Pefablock, 100 mM pepsatin A, 10 mM leupeptin, pH 7.5) using
an Ultra-Turrax, followed by Dounce homogenization, then centrifuged at 1000 g for 15 min. Postnuclear supernatants (75 mg of protein) were applied to 15% SDS-PAGE under reducing conditions and subsequently blotted onto a PVDF membrane. Goat anti-human CTSL antibody (R&D Systems, Wiesbaden, Germany) at a 1:500 dilution and mouse anti-mouse actin antibody (ICN, Biochemicals, Aurora, OH, USA) at 1:5000 dilution were used. The binding of secondary antibody anti-goat IgG-POD (Sigma, Saint Louis, MO, USA) and anti-mouse IgG-POD (Calbiochem, Darmstadt, Germany) at 1:5000 dilution was detected using SuperSignalீ chemiluminescent substrate (Pierce, Rockford, IL, USA).
Detection of CTSL enzyme activity
Fresh tissues (100 mg) were homogenized in 500 ml of NaAc buffer (200 mM sodium acetate, 1 mM EDTA, 0.05% Brij 35) using an Ultra-Turrax, followed by Dounce homogenization, then centrifuged at 1000 g for 15 min. CTSL proteolytic activity was determined by degradation of the fluoropeptide z-Phe-Arg-4-methyl-coumarin-7-amide (20 mM; Bachem, Torrance, CA, USA) in the presence of the CTSB-specific inhibitor CA074 (1.5 mM;
Bachem) at pH 5.5. The release of 7-amino-4-methyl-coumarin was continuously monitored for 45 min by spectrofluorimetry at excitation and emission wavelengths of 360 and 460 nm, respectively.
Histology and immunohistochemistry
For histological assessment, sagittal brain sections of 5 mm in thickness were deparaffinized in xylene, hydrated in graded ethanol solutions and stained with hematoxylin/eosin. Goat antimouse CTSL antibody (R&D Systems) at 1:500 dilution and goat anti-human CTSL antibody (R&D Systems) at 1:50 dilution were used for the detection of murine and human CTSL, respectively. Peroxidase-based detection of the primary antibodies was performed using a Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA, USA) according to the manufacturer's instructions. Microscopy was performed with an Axioplan microscope (Zeiss, Stuttgart, Germany) and digital images were obtained with an Axiocam camera (Zeiss).
